Page last updated: 2024-11-05

thalidomide and Adenovirus Infections, Human

thalidomide has been researched along with Adenovirus Infections, Human in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Adenovirus Infections, Human: Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nicolasora, NP1
Reddy, P1
Kaul, DR1

Other Studies

1 other study available for thalidomide and Adenovirus Infections, Human

ArticleYear
Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Adenoviridae; Adenovirus Infections, Human; Aged; Antigens, Viral; Antiviral Agents; Biopsy; Cidofov

2008